PUBLICATIONS RÉCENTES
Coyac BR, Falgayrac G, Penel G, Schmitt A, Schinke T, Linglart A, McKee MD, Chaussain C, Bardet C. Impaired mineral quality in dentin in X-linked hypophosphatemia. Connect Tissue Res. 2018;59(sup1):91-96
Linglart A, Salles JP. Hypophosphatasia: the contribution of imaging. Arch Pediatr. 2017 May;24(5S2):5S74-5S79.
Linglart A, Mantovani G, Garin I, Usardi A, Elli FM, de Nanclares GP. The Importance of Networking in Pseudohypoparathyroidism: EuroPHP Network and Patient Support Associations. Pediatr Endocrinol Rev. 2017;15(Suppl 1):92-97.
Linglart A, Merzoug V, Lambert AS, Adamsbaum C. Bone dysplasia. Ann Endocrinol (Paris). 2017 Jun;78(2):114-122.
Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, Kamenicky P, Nevoux J, Prié D, Rothenbuhler A, Wicart P, Harvengt P. Endocr Connect.Therapeutic management of hypophosphatemic rickets from infancy to adulthood. 2014 Mar 14;3(1):R13-30.
Lambert AS, Rothenbuhler A, Charles P, Brailly-Tabard S, Trabado S, Célestin E, Durand E, Fontaine I, Miladi L, Wicart P, Bahi-Buisson N, Linglart A. Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility. PLoS One. 2017;12(10):e0186941
Linglart A, Rothenbuhler A. From synthesis to replacement of parathyroid hormone.Lancet Diabetes Endocrinol. 2013 Dec;1(4):260-1
